SCHEMBL8795809

SCHEMBL8795809

CCCCCCCCCCOc1ccc(/C=C(\CO[Si](C)(C)C(C)(C)C)c2cccc(C(=O)OCC)c2)cc1OCCCCCCCCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NMT2 O60551 3/20 0.38
NMT1 P30419 3/20 0.38
TP53 P04637 2/20 0.37
MAPT P10636 1/20 0.37
PTPN11 Q06124 1/20 0.37
PLA2G4A P47712 2/20 0.36
LTB4R Q15722 1/20 0.36
LMNA P02545 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
BCHE P06276 2/20 0.35
ACHE P22303 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8795820 1.00 NPC1 (0.39) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL8796548 0.91 SMPD1 (0.37) CYP1A2CYP2C9HPGDCYP2C19SMN1; SMN2
SCHEMBL8796557 0.91 SMPD1 (0.37) CYP1A2CYP2C9HPGDCYP2C19SMN1; SMN2
SCHEMBL8796565 0.87 PTPN11 (0.37) HPGDSMN1; SMN2PTPN11PLA2G4ALTB4R
SCHEMBL8796569 0.87 PTPN11 (0.37) HPGDSMN1; SMN2PTPN11PLA2G4ALTB4R
SCHEMBL8796294 0.86 PTPN11 (0.36) HPGDSMN1; SMN2PTPN11PLA2G4ALTB4R
SCHEMBL8796289 0.86 PTPN11 (0.36) HPGDSMN1; SMN2PTPN11PLA2G4ALTB4R
SCHEMBL8796082 0.84 NPC1 (0.43) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL8796076 0.84 NPC1 (0.43) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL8797129 0.81 PLA2G4A (0.48) NPC1SMN1; SMN2MAPTPLA2G4ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed